Spironolactone Versus Prednisolone in DMD

Статус выполнения

Ход выполнения

Заболевания

Организация, проводящая КИ

Nationwide Children's Hospital

Цели

This is a randomized, open-label, pilot clinical trial of spironolactone suspension versus oral prednisolone for use in Duchenne muscular dystrophy. The goals are to determine the safety of 6 months of treatment with spironolactone treatment int he steroid-naive DMD population as well as to determine if either spironolactone or a standard clinical dose of corticosteroids results in equivalent improvement in time to complete the 100 meter timed test (100M).

Фаза КИ

I

Количество пациентов

2

Источник